Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetesRCT · 2009 · 156 citations
2. 2Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazoneMeta-Analysis · 2009 · 22 citations
3. 3A Critical Analysis of the Clinical Use of Incretin-Based TherapiesLiterature Review · 2013 · 205 citations
4. 4Lower Baseline Glycemia Reduces Apparent Oral Agent Glucose-Lowering EfficacyOriginal Research · 2006 · 219 citations
5. 5Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379Clinical Guideline · 2013 · 806 citations